Kyung Nam Pharm Co Ltd Cash Flow Conversion Efficiency
Kyung Nam Pharm Co Ltd cash flow conversion efficiency. Based on the latest financial reports, Kyung Nam Pharm Co Ltd (053950) has a cash flow conversion efficiency ratio of 0.001x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩81.44 Million ≈ $55.19K USD) by net assets (₩117.50 Billion ≈ $79.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Kyung Nam Pharm Co Ltd (2007–2025)
Cash flow conversion efficiency of Kyung Nam Pharm Co Ltd from 2007 to 2025. This chart illustrates how Kyung Nam Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 053950 share price today for real-time trading data and today's change.
Kyung Nam Pharm Co Ltd Cash Flow Conversion Ratio Explained
Kyung Nam Pharm Co Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Kyung Nam Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Kyung Nam Pharm Co Ltd ranked by their cash flow conversion efficiency. Also see 053950 company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Global UAV Technologies Ltd
STU:YAB2
|
0.001x |
|
Catenai PLC
LSE:CTAI
|
-0.188x |
|
Sabien Technology Group Plc
LSE:SNT
|
0.043x |
|
Spacefy Inc
F:YSP
|
0.002x |
|
KRUNGTHAI CARD FGN BA 1
F:KRTA
|
-0.012x |
|
Gaucho Group Holdings, Inc.
NASDAQ:VINOQ
|
-0.853x |
|
Next.e.GO N.V.
NASDAQ:EGOXF
|
-0.009x |
|
PHSC PLC
LSE:PHSC
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Kyung Nam Pharm Co Ltd (2007–2025)
The table below shows the annual cash flow conversion efficiency of Kyung Nam Pharm Co Ltd from 2007 to 2025. Review Kyung Nam Pharm Co Ltd (053950) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | ₩108.30 Billion ≈ $73.39 Million |
₩-1.68 Billion ≈ $-1.14 Million |
-0.016x | -197.34% |
| 2024-12-31 | ₩115.22 Billion ≈ $78.09 Million |
₩1.84 Billion ≈ $1.25 Million |
0.016x | +106.72% |
| 2023-12-31 | ₩89.83 Billion ≈ $60.88 Million |
₩693.30 Million ≈ $469.84K |
0.008x | +911.06% |
| 2022-12-31 | ₩93.77 Billion ≈ $63.55 Million |
₩71.58 Million ≈ $48.51K |
0.001x | -98.33% |
| 2020-12-31 | ₩57.36 Billion ≈ $38.87 Million |
₩2.62 Billion ≈ $1.77 Million |
0.046x | +143.42% |
| 2019-12-31 | ₩61.19 Billion ≈ $41.47 Million |
₩-6.43 Billion ≈ $-4.35 Million |
-0.105x | -73.03% |
| 2018-12-31 | ₩28.91 Billion ≈ $19.59 Million |
₩-1.75 Billion ≈ $-1.19 Million |
-0.061x | -120.88% |
| 2016-12-31 | ₩16.82 Billion ≈ $11.40 Million |
₩4.89 Billion ≈ $3.31 Million |
0.291x | +1223.07% |
| 2010-12-31 | ₩21.97 Billion ≈ $14.89 Million |
₩482.65 Million ≈ $327.08K |
0.022x | +119.25% |
| 2007-12-31 | ₩14.85 Billion ≈ $10.06 Million |
₩148.79 Million ≈ $100.84K |
0.010x | -- |
About Kyung Nam Pharm Co Ltd
Kyung Nam Pharm Co.,Ltd. manufactures pharmaceuticals. The company offers over-the-counter products, including antipyretics, analgesics, and antiphlogistics; medications for skin diseases and athlete's foot; pain relief patches/creams, antitussives, mucolytic agents, and expectorants; gastro protective agents/digestives; periodontal/gum disease drugs; medications for liver diseases; ear and nose … Read more